Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Biphenotypic, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Methotrexate 29Cytarabine 28Vincristine 26Cyclophosphamide 25Mercaptopurine 20Dexamethasone 20pegaspargase 18Prednisone 17Doxorubicin 17Daunorubicin 16Asparaginase 15merphos 14Calcium Dobesilate 14Thioguanine 13Leucovorin 13Radiotherapy 11Hydrocortisone 10azathiopurine 9Filgrastim 9Etoposide 9Granulocyte Colony-Stimulating Factor 8dexamethasone acetate 7dexamethasone 21-phosphate 7auricularum 7Specimen Handling 7prednylidene 6deltacortene 6Whole-Body Irradiation 6Methylprednisolone 6fludarabine phosphate 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Precursor Cell Lymphoblastic Leukemia-Lymphoma × lestaurtinib × Clear all
NCT00557193 2024-07-15

Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Children's Oncology Group

Phase 3 Completed
218 enrolled 21 charts
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡